Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.
about
Statins for children with familial hypercholesterolemiaStatins for children with familial hypercholesterolemiaStandards of medical care in diabetes--2012Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesPediatric Statin Administration: Navigating a Frontier with Limited DataStandards of medical care in diabetes--2013Standards of medical care in diabetes--2010.The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice.Long-term pharmacotherapy for elevated low density lipoprotein levels in children: A retrospective analysisDyslipidemia in children and adolescents: when and how to diagnose and treat?The safety of statins in children.Standards of medical care in diabetes--2011.Use of statins for dyslipidemia in the pediatric population.Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemiaHypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years.Biochemical effects, hypolipidemic and anti-inflammatory activities of Artemisia vulgaris extract in hypercholesterolemic ratsEffect of age on lipid profiles in pediatric heart transplant recipients.Torcetrapib/atorvastatin combination therapy.Management of hereditary dyslipidaemia; the paradigm of autosomal dominant hypercholesterolaemia.Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.Standards of medical care in diabetes--2009.Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.Atherosclerosis prevention and treatment in children and adolescents.Risks and benefits of statin use in young people with type 1 diabetes.Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia.Statin therapy across the lifespan: evidence in major age groups.Statins for children with familial hypercholesterolemia.Prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes in Austria.Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives.Cholesterol screening in children: makes sense but what is the impact?Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank.Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases.High-Throughput Assay for Enantiomeric Excess Determination in 1,2- and 1,3-Diols and Direct Asymmetric Reaction Screening.Cholesterol screening and management in children and young adults should start early--NO!The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.Dual Wavelength Spectrophotometric Method for Simultaneous Estimation of Atorvastatin Calcium and Felodipine from Tablet Dosage Form
P2860
Q24194816-DE33753F-DEE3-4068-87E6-479F55925259Q24234081-601E0616-6D9C-478F-A8EF-675F9840337DQ24632533-E561D8CD-E0D0-48AE-BFCA-3E8D9DD4AD2BQ26853571-EB1EE7CD-3638-45B6-B9E0-0A74F32BADA5Q28068014-9BD9ECF1-054A-4FAE-97F0-B080E296289EQ29620309-EF0F4DCF-54E6-47B5-BD09-9388844F3881Q33554238-A8C93F99-7DC4-4804-BBC9-D0F04AA8A40BQ33635194-43C3FBF1-3C3F-4533-AA77-4E269CD436B2Q33924782-0835B338-3FD9-4F82-9F19-7C71DF71C325Q33935174-BCCF8BCB-F899-4025-83BD-6C054B0090B0Q34342024-F66DFCBA-495C-4408-A30F-00DC53C9A43EQ34425055-D6430FB0-AC32-4EB0-9739-0C210ACEDAEFQ34477252-34F471AE-B755-452F-85D5-AD64CE5E407CQ34499298-DA70AFDF-CE9F-4184-8BB6-D2D499195031Q34700305-11DA9F3A-B7F9-4883-989E-523D0A385723Q35777404-DC271F98-6727-4F82-9F33-D1D349D4172EQ35799689-9DE66242-FB54-4E3A-ABFF-5FD90EBF044FQ35883191-B78DD423-43E0-4842-BCE3-99A2BC02C980Q36209771-F1F1E75F-3B35-44F5-92A5-801AEEEE08DBQ36265996-2EC98E4C-37F0-4F7C-A236-4DA9FC9AC974Q36270428-0BD25B0F-2115-4CC9-817D-EE6B7457BD07Q36965617-91605E60-F277-43AA-82A1-D28214649C93Q37036416-55D320C8-2E2D-465F-83A1-C075F3B1E462Q37428048-0B8E4D2A-9A68-43EF-9B4E-C68F2C2BEA57Q37732240-A02C0F4A-C4D4-4308-9156-36CEB501BFC3Q38209424-9E7904A5-3F75-423D-9647-70D3EAC84B2BQ38218145-B2142724-7C29-4613-9126-FE68AB64F767Q38660929-AE9840E9-3D68-46F0-85CD-7A59D5D0ADABQ38689931-C7792088-E142-4F01-AEC3-6CACF8B38204Q39640211-B74FA21D-BA85-4BF2-94AC-76B4FED736D6Q40504034-EAAAC5BA-41F7-464B-8452-2FE11F631F20Q41503652-84F4F887-C82E-48CD-AB28-05525170B2EEQ43065808-7D6B1D4A-352F-4538-8DEB-8B91015ECE02Q50027860-54EEBE56-482D-4868-BDB6-C50B3912D409Q50075636-34DB2B31-3674-473A-8F01-75DB0F60758AQ50201191-251AB5E1-00C5-4548-BBCF-9924FB14850BQ50895846-26EFF217-0188-473D-B099-AF239040648CQ54608986-7AF98925-A903-4E71-AEE0-BA3D652D9D9DQ55176268-C7928F9C-2C67-4AB2-B11D-FBF234DA6E70Q59043352-2DCCDA6B-5E4E-4A89-AD3C-659CAF387DAC
P2860
Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@ast
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@en
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@nl
type
label
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@ast
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@en
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@nl
prefLabel
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@ast
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@en
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@nl
P2093
P921
P1476
Efficacy and safety of atorvas ...... zed, placebo-controlled trial.
@en
P2093
A David Marais
Brian W McCrindle
P356
10.1016/S0022-3476(03)00186-0
P407
P577
2003-07-01T00:00:00Z